The neuronal cell-surface molecule mitogenic for Schwann cells is a heparin-binding protein.
The cell surface of embryonic peripheral neurons provides a mitogenic stimulus for Schwann cells. We report (i) the solubilization of this mitogenic activity from rat dorsal root ganglion neurons grown in tissue culture and (ii) the solubilization and partial purification of mitogenic activity from neonatal rat brains. Extracted mitogenic activity is peripheral rather than intrinsic to the membrane, stable after extraction, and active as a mitogen in the absence of serum (the most stringent criterion defining the neuronal mitogen). We have previously provided evidence suggesting that a neuronal cell-surface heparan sulfate proteoglycan is required for expression of the neurons' mitogenic activity. We now show that mitogenic activity can be extracted from the membrane dissociated from proteoglycan as assayed by its ability to bind to immobilized heparin. After dissociation, low concentrations of heparin (1 micrograms/ml) inhibit the ability of the mitogen to stimulate Schwann cell division. Basic fibroblast growth factor (FGF) is weakly mitogenic for Schwann cells, but it is not present in mitogenic brain extracts (based on immunoblotting). Immunodepletion experiments with specific antibodies to FGF indicate that the mitogenic activity extracted from neurons is not a form of this heparin-binding mitogen. Acidic FGF is not mitogenic for Schwann cells and is not present in mitogenic brain extracts. We suggest that these and previous data indicate the neurite mitogen is a proteoglycan-growth factor complex that limits mitogenic activity to the axonal surface, protects mitogen against inactivation by other proteoglycans, and provides for effective presentation of mitogen to the Schwann cell.
Ratner
N
N
Department of Anatomy, University of Cincinnati Medical School, OH 45267-0521.
Hong
D M
DM
Lieberman
M A
MA
Bunge
R P
RP
Glaser
L
L
D000818:Animals; D001923:Brain Chemistry; D002352:Carrier Proteins / Q000302:isolation & purification / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects; D005346:Fibroblast Growth Factors / Q000494:pharmacology; D005727:Ganglia, Spinal / Q000166:cytology*; D006133:Growth Substances / Q000494:pharmacology; D006493:Heparin / Q000378:metabolism* / Q000494:pharmacology; D008934:Mitogens / Q000302:isolation & purification / Q000494:pharmacology*; D009474:Neurons / Q000032:analysis*; D051381:Rats; D012583:Schwann Cells / Q000166:cytology* / Q000187:drug effects; D012995:Solubility
D002352:Carrier Proteins; D006133:Growth Substances; D008934:Mitogens; D005346:Fibroblast Growth Factors; D006493:Heparin